4.55 USD
↗ 0.11 (2.57%)PRE MARKET (AS OF 07:54 PM EDT)
Relmada Therapeutics, Inc. Common Stock
RLMDNASDAQ • USD
Market: OPEN
Shares of Relmada Therapeutics, Inc. Common Stock (RLMD) are trading at $4.55. Our models show a "Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, RLMD appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Sep 15, 2026.
Open?$4.44
High?$4.56
Low?$4.31
Prev. Close?$4.44
Volume?1.8M
Avg. Volume?1.2M
VWAP?$4.40
Rel. Volume?1.48x
Bid / Ask
Bid?$3.78 × 100
Ask?$5.31 × 100
Spread?$1.53
Midpoint?$4.55
Valuation & Ratios
Market Cap?473.6M
Shares Out?106.7M
Float?86.9M
Float %?81.5%
P/E Ratio?N/A
P/B Ratio?2.29
EPS?-$0.58
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.
Themes
Employees
17
Market Cap
473.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2014-03-03
Address
2222 PONCE DE LEON BLVD. 3RD FLOOR
CORAL GABLES, FL 33134
Phone: 646 876 3459
CORAL GABLES, FL 33134
Phone: 646 876 3459
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?34
Piotroski F-Score?0/9Weak
Altman Z-Score?18.24Safe
Confidence?48%Low
Short InterestVery High
Short % of Float?15.65%High
Short Interest?13.6M
Days to Cover?17.7
Free Float86.9M
Avg Daily Volume768.2K
Settlement Date2026-08-31
Financial Health
Current Ratio?29.52Strong
Quick Ratio?29.52Strong
Cash Ratio?1.53Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.29CHEAP▾
Peers100
S&P68
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-7.1CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-30.0%WEAK▾
S&P6
ROA?-28.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-45992000
Enterprise Value?$462.3M
Fundamentals ratios updated end of day